Picture of Pure Extracts Technologies logo

PULL Pure Extracts Technologies Balance Sheet

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Pure Extracts Technologies, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
R2019
December 31st
2021
June 30th
2022
June 30th
Period Length:
Source:ARSARSInterim ReportARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:
fx
Final
fx
Final
FinalFinalFinal
Cash
Cash and Short Term Investments0.0140.0540.031.630.111
Net Total Accounts Receivable
Net Total Receivables0.0010.0030.0030.620.463
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets0.0150.0570.0323.292.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment5.053.96
Other Long Term Assets
Total Assets0.0150.0570.0328.56.32
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.530.1820.2341.023.16
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities0.530.1820.2342.333.84
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity-0.515-0.125-0.2016.172.48
Total Liabilities & Shareholders' Equity0.0150.0570.0328.56.32
Total Common Shares Outstanding